Pricing Log in Create free account
Saturday 7 November 2026 Export HCA’s income statement to Excel — free account

HCA Healthcare, Inc.

HCA Healthcare Medical Care Facilities

HCA Healthcare, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $75.6 billion, up 7.08% from fiscal 2024.

Revenue
+3.59%
EPS
+23.8%
Free cash flow
−0.77%
Total debt
+13.4%

Quarter to September 2026, against a year earlier

496.04 11.44 −2.25%
Market cap
$106.0B
P/E
15.7×
Fwd P/E
15.6×
Dividend yield
0.62%
F-score
7/9
Altman Z
2.80
Beneish M
−2.87
Dividend safety
78/100
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

HCA Healthcare, Inc. (HCA) SEC filings, changes and red flags

Red flags

Filings

Form Period Filed What it reports Flags
8-K Nov 2, 2026 1.01 Entry into a material definitive agreement; 2.03 Creation of a direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits
8-K Nov 2, 2026 8.01 Other events; 9.01 Financial statements and exhibits
10-Q Sep 30, 2026 P1I2: 7 added · 6 removed · 29 modified
P2I1A: no comparison — incorporated by reference
8-K Oct 27, 2026 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits
8-K Jul 29, 2026 2.03 Creation of a direct financial obligation; 8.01 Other events
10-Q Jun 30, 2026 P1I2: 21 added · 7 removed · 33 modified
P2I1A: no comparison — incorporated by reference
8-K Jul 24, 2026 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits
8-K Jul 14, 2026 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Jun 15, 2026 5.02 Departure or appointment of directors or officers Officer departure
8-K Apr 27, 2026 1.01 Entry into a material definitive agreement; 2.03 Creation of a direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits
10-Q Mar 31, 2026 P1I2: 6 added · 23 removed · 35 modified
P2I1A: no comparison — incorporated by reference
8-K Apr 23, 2026 5.07 Submission of matters to a vote of security holders
8-K Apr 27, 2026 8.01 Other events; 9.01 Financial statements and exhibits
8-K Apr 24, 2026 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits
8-K Feb 20, 2026 5.02 Departure or appointment of directors or officers; 9.01 Financial statements and exhibits
10-K Dec 31, 2025 1: 18 added · 19 removed · 105 modified
1A: 15 added · 16 removed · 67 modified
7: 8 added · 3 removed · 34 modified
8-K Jan 27, 2026 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits
8-K Oct 27, 2025 1.01 Entry into a material definitive agreement; 2.03 Creation of a direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits
10-Q Sep 30, 2025 P1I2: 7 added · 1 removed · 36 modified
P2I1A: no comparison — incorporated by reference
8-K Oct 27, 2025 8.01 Other events; 9.01 Financial statements and exhibits
8-K Oct 24, 2025 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits
10-Q Jun 30, 2025 P1I2: 19 added · 3 removed · 33 modified
P2I1A: 7 removed · 3 modified
8-K Jul 25, 2025 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits
10-Q Mar 31, 2025
8-K Apr 25, 2025 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits
10-K Dec 31, 2024 1: no comparison — no earlier filing on file
1A: no comparison — no earlier filing on file
7: no comparison — no earlier filing on file
8-K Jan 24, 2025 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits
10-Q Sep 30, 2024
8-K Oct 25, 2024 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits
10-Q Jun 30, 2024
8-K Jul 23, 2024 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits
8-K Apr 26, 2024 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits
8-K Jan 24, 2024 2.02 Results of operations and financial condition; 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits

From the company’s filings on sec.gov. Red flags are raised by rules over the filings’ own data and text; they are not investment advice.